Yoon et al showed previously that FGFb protein expression is reduced in bone marrow mesenchymal cells of patients with MPNs using computerized image analysis of immunohistochemical stains [51] while simultaneously increased in the malignant megakaryocytes of MPN patients. This evidence concerns the gene FGF2 and myeloproliferative disorder.